Full
Outline
So as to provide a reference for optimizing the pharmaceutical care model for resident pharmacists in obstetrics and gynecology, and to evaluate its impact on rational drug use and healthcare quality. This aims to provide a reference for optimizing the pharmaceutical care model of resident pharmacists in these departments.
A retrospective study was conducted. Data on clinical pharmaceutical services from the Obstetrics and Gynecology Department of a hospital were compared before (January 2024-December 2024, control group) and after (January 2025-December 2025, intervention group) the implementation of the resident pharmacist model. Core indicators included the Antibiotic Use Density (AUD), rational use rate of antibiotics for type II incisions, number of reported adverse drug reactions (ADRs), and drug proportion control and medication cost control. This was combined with a comparative analysis of online and offline service data from the pregnancy and lactation pharmacy clinic.
Following implementation, the pregnancy and lactation pharmacy clinic completed 568 offline consultations and 1 121 online consultations. Clinical affinity was significantly improved (P<0.01). Core rational medication use indicators showed marked improvement: AUD decreased by 13.5% in obstetrics and 23.7% in gynecology (both P<0.01). The rational use rate of antibiotics for type II incisions improved significantly (P<0.01). The acceptance rate of antibiotic consultation recommendations reached 100% in both departments. ADR reporting increased. The drug proportion and average per capita drug cost were significantly decreased. The intravenous infusion rate and average length of stay in gynecology were both significantly decreased (P<0.01). After the implementation of fees for the pharmacy clinic, the pregnancy and lactation clinic conducted 392 fee-based consultations, averaging 28 per month, exceeding the average monthly number of consultations before charging. Following the implementation of the inpatient consultation fee (clinical pharmacy) policy, 732 cases of medication therapy management were conducted.
The collaborative model integrating the pharmacy clinic with resident pharmacists effectively addresses clinical pain points through medication risk assessment and medication optimization. It enhances physician-pharmacist collaboration, significantly improves rational drug use indicators, and achieves tripartite collaboration among physicians, pharmacists, and patients. This model provides a innovative solution for medication safety in special populations and which is worthy of promotion and application.
197
38
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
